Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (301-310 of 894) with videos related to

Pageof 90
Sort By:
Journal of the American Society of Nephrology : JASN|December 1, 2023
Authors' Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?Norberto Perico, Matthew D Griffin, Federica Casiraghi, et al.
Fibrogenesis & Tissue Repair|May 6, 2010
The role of renin angiotensin system inhibition in kidney repairIrene M van der Meer, Paolo Cravedi, Giuseppe Remuzzi
Hypertension (Dallas, Tex. : 1979)|May 5, 2010
Oral acetyl-L-carnitine therapy and insulin resistancePiero Ruggenenti, Irene M van der Meer, Giuseppe Remuzzi
BMJ Case Reports|January 26, 2020
Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sicknessManuel Alfredo Podestà, Barbara Ruggiero, Giuseppe Remuzzi, et al.
Lancet (London, England)|November 16, 2004
Delayed graft function in kidney transplantationNorberto Perico, Dario Cattaneo, Mohamed H Sayegh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathyPaolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni, et al.
Journal of Renal Care|July 1, 2010
The diabetic CKD patient--a major cardiovascular challengeIrene M van der Meer, Piero Ruggenenti, Giuseppe Remuzzi
Contributions to Nephrology|July 10, 2002
Effect of hemodynamic conditions on arteriovenous fistula for hemodialysis accessBogdan Ene-Iordache, Simona Bruno, Andrea Remuzzi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2009
Enzyme replacement therapy and Fabry nephropathyDavid G Warnock, Erica Daina, Giuseppe Remuzzi, et al.
Kidney International|October 14, 2011
The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesWilliam G Couser, Giuseppe Remuzzi, Shanthi Mendis, et al.
Pageof 90

Showing results (301-310 of 894) with videos related to

Sort By:
Pageof 90
Journal of the American Society of Nephrology : JASN|December 1, 2023
Authors' Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?Norberto Perico, Matthew D Griffin, Federica Casiraghi, et al.
Fibrogenesis & Tissue Repair|May 6, 2010
The role of renin angiotensin system inhibition in kidney repairIrene M van der Meer, Paolo Cravedi, Giuseppe Remuzzi
Hypertension (Dallas, Tex. : 1979)|May 5, 2010
Oral acetyl-L-carnitine therapy and insulin resistancePiero Ruggenenti, Irene M van der Meer, Giuseppe Remuzzi
BMJ Case Reports|January 26, 2020
Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sicknessManuel Alfredo Podestà, Barbara Ruggiero, Giuseppe Remuzzi, et al.
Lancet (London, England)|November 16, 2004
Delayed graft function in kidney transplantationNorberto Perico, Dario Cattaneo, Mohamed H Sayegh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathyPaolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni, et al.
Journal of Renal Care|July 1, 2010
The diabetic CKD patient--a major cardiovascular challengeIrene M van der Meer, Piero Ruggenenti, Giuseppe Remuzzi
Contributions to Nephrology|July 10, 2002
Effect of hemodynamic conditions on arteriovenous fistula for hemodialysis accessBogdan Ene-Iordache, Simona Bruno, Andrea Remuzzi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2009
Enzyme replacement therapy and Fabry nephropathyDavid G Warnock, Erica Daina, Giuseppe Remuzzi, et al.
Kidney International|October 14, 2011
The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesWilliam G Couser, Giuseppe Remuzzi, Shanthi Mendis, et al.
Pageof 90